148. A drug is recalled from the market due to unacceptable severe adverse effects identified through post-marketing surveillance. What medicinal epidemiological outcome does this represent?
A.
A successful drug launch.
B.
A regulatory failure.
C.
A successful pharmacovigilance system detecting a significant safety signal.
✓
D.
A minor inconvenience for patients.
📖 Additional Information
A successful drug launch.
A regulatory failure.
A successful pharmacovigilance system detecting a significant safety signal.
